<DOC>
	<DOCNO>NCT01332474</DOCNO>
	<brief_summary>To collect background characteristic juvenile cerebral palsy patient age 2-year old prescribed BOTOX treatment equine foot due low limb spasticity , compare patient whose death adverse drug reaction ( ADRs ) relate possible spread toxin report spontaneous ADR reporting system , discuss potential risk factor ADRs .</brief_summary>
	<brief_title>JCP Study Investigation Patient Background Characteristics</brief_title>
	<detailed_description>1 . In prospective medical institution ( BOTOX expect prescribe annually least 10 juvenile cerebral palsy patient age 2-year older ) , Medical Representative explain objective , subject method investigation prospective investigator ( i.e. , physician prescribe BOTOX comply protocol investigation ) ask his/her participation investigation . 2 . When physician agrees participate investigation , write agreement conclude GSK head ( e.g . director ) medical institution prior start investigation . 3 . After completion investigation period , physician complete case report form ( CRF ) patient prescribe BOTOX him/her investigation period . The information patient develop ADRs collect separately spontaneous ADR reporting system daily basis .</detailed_description>
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>Background factor : The follow background characteristic compare patient collect investigation patient whose death ADRs relate possible spread toxin report spontaneous ADR reporting system , discuss potential risk factor death spread toxin : 1. severity indication ( cerebral palsy ) prior use BOTOX 2 . Medical history/concurrent medical condition ( e.g. , dysphagia , seizure , pulmonary disorder , neuromuscular disorder , cardiac disorder , others ) ; Yes/No , yes , specify diseases 3 . Use concomitant drug nondrug therapy 4 . Dose per kg body weight 5 . Dose per injection site ( e.g. , gastrocnemius muscle , soleus muscle , tibialis posterior muscle ) patient whose adverse drug reaction ( ADRs )</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Botox</keyword>
	<keyword>JCP</keyword>
</DOC>